Slingshot members are tracking this corporate initiative:
Lilly (LLY) and Merck (MRK) Expand Existing Oncology Collaboration, Agree to Evaluating Lartruvo + Keytruda in Advanced/Metastatic Soft Tissue Sarcoma
Slingshot Insights Explained
Strategic Initiative Date
Announcement Date: Jan 11, 2017 Projected Implementation: Q1, 2017 Relevance Tracked Until: Q1, 2019
Don’t see a project related to the strategic initiative you care about?
Related Keywords Collaboration, Lartruvo, Keytuda, Advanced Soft Tissue Sarcoma, Metastatic Soft Tissue Sarcoma